vs
MANNKIND CORP（MNKD）与RMR GROUP INC.（RMR）财务数据对比。点击上方公司名可切换其他公司
MANNKIND CORP的季度营收约是RMR GROUP INC.的1.7倍（$112.0M vs $66.7M），RMR GROUP INC.净利率更高（18.3% vs -14.2%，领先32.5%），MANNKIND CORP同比增速更快（45.8% vs 40.8%）
曼凯德公司是一家生物制药企业，成立于1991年2月，总部位于美国康涅狄格州丹伯里，专注于糖尿病、肺动脉高压等疾病治疗药物的研发、生产及商业化推广，致力于为相关患者提供创新的治疗方案。
RMR集团是总部位于美国的另类资产管理企业，核心业务聚焦不动产及相关投资，覆盖商业地产、住宅物业、基础设施等赛道，服务全球核心市场的机构投资者、高净值人士及零售客户。
MNKD vs RMR — 直观对比
营收规模更大
MNKD
是对方的1.7倍
$66.7M
营收增速更快
MNKD
高出5.1%
40.8%
净利率更高
RMR
高出32.5%
-14.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $112.0M | $66.7M |
| 净利润 | $-15.9M | $12.2M |
| 毛利率 | 87.6% | — |
| 营业利润率 | -6.9% | 48.1% |
| 净利率 | -14.2% | 18.3% |
| 营收同比 | 45.8% | 40.8% |
| 净利润同比 | -314.9% | 91.1% |
| 每股收益（稀释后） | $-0.05 | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MNKDRMR
| Q4 25 | $112.0M | $66.7M | ||
| Q3 25 | $82.1M | — | ||
| Q2 25 | $76.5M | — | ||
| Q1 25 | $78.4M | — | ||
| Q4 24 | $76.8M | — | ||
| Q3 24 | $70.1M | — | ||
| Q2 24 | $72.4M | — | ||
| Q1 24 | $66.3M | — |
净利润MNKDRMR
| Q4 25 | $-15.9M | $12.2M | ||
| Q3 25 | $8.0M | — | ||
| Q2 25 | $668.0K | — | ||
| Q1 25 | $13.2M | — | ||
| Q4 24 | $7.4M | — | ||
| Q3 24 | $11.6M | — | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | $10.6M | — |
毛利率MNKDRMR
| Q4 25 | 87.6% | — | ||
| Q3 25 | 94.5% | — | ||
| Q2 25 | 94.0% | — | ||
| Q1 25 | 95.2% | — | ||
| Q4 24 | 93.7% | — | ||
| Q3 24 | 95.4% | — | ||
| Q2 24 | 92.3% | — | ||
| Q1 24 | 94.2% | — |
营业利润率MNKDRMR
| Q4 25 | -6.9% | 48.1% | ||
| Q3 25 | 23.0% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 28.5% | — | ||
| Q4 24 | 34.5% | — | ||
| Q3 24 | 18.2% | — | ||
| Q2 24 | 22.9% | — | ||
| Q1 24 | 25.2% | — |
净利率MNKDRMR
| Q4 25 | -14.2% | 18.3% | ||
| Q3 25 | 9.7% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 16.8% | — | ||
| Q4 24 | 9.7% | — | ||
| Q3 24 | 16.5% | — | ||
| Q2 24 | -2.8% | — | ||
| Q1 24 | 16.0% | — |
每股收益（稀释后）MNKDRMR
| Q4 25 | $-0.05 | $0.71 | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.00 | — | ||
| Q1 25 | $0.04 | — | ||
| Q4 24 | $0.03 | — | ||
| Q3 24 | $0.04 | — | ||
| Q2 24 | $-0.01 | — | ||
| Q1 24 | $0.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $171.3M | $49.3M |
| 总债务越低越好 | $354.6M | — |
| 股东权益账面价值 | $-51.0M | $232.7M |
| 总资产 | $792.2M | $687.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MNKDRMR
| Q4 25 | $171.3M | $49.3M | ||
| Q3 25 | $260.0M | — | ||
| Q2 25 | $179.0M | — | ||
| Q1 25 | $181.5M | — | ||
| Q4 24 | $197.3M | — | ||
| Q3 24 | $251.6M | — | ||
| Q2 24 | $247.8M | — | ||
| Q1 24 | $300.7M | — |
总债务MNKDRMR
| Q4 25 | $354.6M | — | ||
| Q3 25 | $109.7M | — | ||
| Q2 25 | $36.2M | — | ||
| Q1 25 | $36.1M | — | ||
| Q4 24 | $36.1M | — | ||
| Q3 24 | $227.9M | — | ||
| Q2 24 | $227.6M | — | ||
| Q1 24 | $264.1M | — |
股东权益MNKDRMR
| Q4 25 | $-51.0M | $232.7M | ||
| Q3 25 | $-44.6M | — | ||
| Q2 25 | $-55.0M | — | ||
| Q1 25 | $-58.6M | — | ||
| Q4 24 | $-78.8M | — | ||
| Q3 24 | $-209.9M | — | ||
| Q2 24 | $-225.8M | — | ||
| Q1 24 | $-230.0M | — |
总资产MNKDRMR
| Q4 25 | $792.2M | $687.1M | ||
| Q3 25 | $494.6M | — | ||
| Q2 25 | $411.7M | — | ||
| Q1 25 | $410.1M | — | ||
| Q4 24 | $393.8M | — | ||
| Q3 24 | $464.2M | — | ||
| Q2 24 | $443.8M | — | ||
| Q1 24 | $480.9M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.0M | $10.7M |
| 自由现金流经营现金流 - 资本支出 | $-10.0M | — |
| 自由现金流率自由现金流/营收 | -8.9% | — |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | — | 0.88× |
| 过去12个月自由现金流最近4个季度 | $13.7M | — |
8季度趋势，按日历期对齐
经营现金流MNKDRMR
| Q4 25 | $-8.0M | $10.7M | ||
| Q3 25 | $23.6M | — | ||
| Q2 25 | $8.9M | — | ||
| Q1 25 | $-6.4M | — | ||
| Q4 24 | $22.6M | — | ||
| Q3 24 | $9.3M | — | ||
| Q2 24 | $3.8M | — | ||
| Q1 24 | $6.7M | — |
自由现金流MNKDRMR
| Q4 25 | $-10.0M | — | ||
| Q3 25 | $22.5M | — | ||
| Q2 25 | $7.8M | — | ||
| Q1 25 | $-6.7M | — | ||
| Q4 24 | $19.7M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $861.0K | — | ||
| Q1 24 | $4.3M | — |
自由现金流率MNKDRMR
| Q4 25 | -8.9% | — | ||
| Q3 25 | 27.4% | — | ||
| Q2 25 | 10.2% | — | ||
| Q1 25 | -8.6% | — | ||
| Q4 24 | 25.7% | — | ||
| Q3 24 | 11.3% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 6.5% | — |
资本支出强度MNKDRMR
| Q4 25 | 1.8% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | 3.6% | — |
现金转化率MNKDRMR
| Q4 25 | — | 0.88× | ||
| Q3 25 | 2.96× | — | ||
| Q2 25 | 13.40× | — | ||
| Q1 25 | -0.48× | — | ||
| Q4 24 | 3.05× | — | ||
| Q3 24 | 0.81× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.63× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MNKD
| Products | $50.4M | 45% |
| Royalty | $33.6M | 30% |
| Afrezza | $22.9M | 20% |
| V Go | $4.3M | 4% |
RMR
| Management Service Incentive | $23.6M | 35% |
| Industrial Logistics Properties Trust | $15.1M | 23% |
| Managed Private Real Estate Capital | $11.1M | 17% |
| Office Properties Income Trust | $5.6M | 8% |
| Other Private Entities | $5.3M | 8% |
| RMR Residential | $3.4M | 5% |
| Sonesta International Hotels Corporation | $2.1M | 3% |
| Investment Advisory Management And Administrative Service | $1.2M | 2% |
